Bristol Myers Squibb (BMS) has reported a 9% growth in revenue to $46.4bn for full-year 2021 compared with $42.52 in 2020. During the year, net product sales surged to $45.1bn
Analog Devices Inc., which has two chip factories in the Portland area, says it’s increasing production at both of them and adding staff in response to soaring demand. The Massachusetts-based
JPMorgan Multi-Asset Growth & Income plc (LON:MATE) published their commentary for December 2021. Month in review The trust delivered a positive return on net assets in December. Our bespoke equity sleeve – which is run
THE WHAT? Procter & Gamble-owned Pantene has teamed up with ‘impressive, strong, modern, multi-hyphenate women’ to form the new Pantene Conditioner Collective. THE DETAILS Partners of the collective include Chloe Fineman, who
Shoppers shrugged off rising prices last year on products like Pampers diapers and Charmin toilet paper, Procter & Gamble said on Wednesday in announcing a jump in its second-quarter earnings.
When it comes to cystic fibrosis Vertex is the undisputed heavyweight, but this has not stopped other groups from taking it on. Abbvie is the latest challenger, and data due
The collaboration between Bristol Myers Squibb and Century Therapeutics will combine Century’s iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development. Bristol
Italy will receive around 40,000 doses of Merck & Co’s (MRK.N) COVID-19 antiviral drug next week, which will add to nearly 12,000 already distributed to hospitals, the special COVID-19 commissioner
Two doses of the Johnson & Johnson (J&J) Covid-19 vaccine cut the risk of hospitalisation by up to 85 per cent, according to a South African study conducted when the
The Directors of JPMorgan Multi-Asset Growth & Income plc (LON:MATE) have declared the following distribution: Third interim distribution A third interim distribution of 1.025 pence per ordinary share, for the year ending
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
